Clinical Research Institute S.C.

Tlalnepantla, State of Mexico C.P. 54055

0 studies enrolling now · 8 studies all time

What they study most

Erosive Esophagitis, Gastroesophageal Reflux Disease (GERD), Influenza, Migraine, Moderate to Severe Plaque Psoriasis, Plaque Type Psoriasis, Psoriasis, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old — Completed
• Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications — Completed
• A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old — Stopped early
• Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use — Completed
• MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
• Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed